Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:35 pm Purchase |
2024-09-30 | 13G | SeaStar Medical Holding Corporation ICU |
Ayrton Capital LLC | 294,361 6.600% |
294,361 (New Position) |
Filing History |
| 2024-11-14 5:34 pm Purchase |
2024-09-30 | 13G | Trio Petroleum Corp. TPET |
Ayrton Capital LLC | 238,371 8.600% |
238,371 (New Position) |
Filing History |
| 2024-11-14 5:34 pm Purchase |
2024-09-30 | 13G | KWESST Micro Systems Inc. KWE |
Ayrton Capital LLC | 1,185,000 7.100% |
1,185,000 (New Position) |
Filing History |
| 2024-11-14 5:32 pm Purchase |
2024-09-30 | 13G | Genius Group Limited GNS |
Ayrton Capital LLC | 1,953,162 8.300% |
1,953,162 (New Position) |
Filing History |
| 2024-11-14 5:24 pm Purchase |
2024-09-30 | 13G | China Natural Resources, Inc. CHNR |
Ayrton Capital LLC | 557,951 5.400% |
557,951 (New Position) |
Filing History |
| 2024-11-14 5:23 pm Purchase |
2024-06-24 | 13G | VSee Health, Inc. VSEE |
Ayrton Capital LLC | 127,012 0.900% |
127,012 (New Position) |
Filing History |
| 2024-11-14 5:17 pm Purchase |
2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 672,910 6.500% |
428,619 (+175.45%) |
Filing History |
| 2024-07-08 3:49 pm Purchase |
2023-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 4,955,698 9.900% |
3,792,069 (+325.88%) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Arcimoto, Inc. FUVV |
Ayrton Capital LLC | 950,501 9.900% |
950,501 (New Position) |
Filing |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Addentax Group Corp. ATXG |
Ayrton Capital LLC | 431,403 9.900% |
431,403 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Digital Health Acquisition Corp. DHAC |
Ayrton Capital LLC | 200,000 5.300% |
200,000 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Esports Entertainment Group, Inc. GMBL |
Ayrton Capital LLC | 118,121 9.900% |
118,121 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Sale |
2023-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 1,163,629 9.900% |
-1,058,593 (-47.64%) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Ocean Biomedical, Inc. OCEA |
Ayrton Capital LLC | 3,781,766 9.900% |
3,781,766 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | PAVmed Inc. PAVM |
Ayrton Capital LLC | 851,018 9.900% |
851,018 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 244,291 9.900% |
244,291 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Sale |
2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 956,229 9.900% |
-794,483 (-45.38%) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
Ayrton Capital LLC | 4,097,134 9.900% |
4,097,134 (New Position) |
Filing History |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | Tritium DCFC Limited DCFC |
Ayrton Capital LLC | 91,940 9.900% |
91,940 (New Position) |
Filing History |
| 2023-05-19 5:19 pm Purchase |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 1,750,712 9.990% |
1,750,712 (New Position) |
Filing History |